Intake of dietary flavonoids and risk of epithelial ovarian cancer.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMC 4196485)

Published in Am J Clin Nutr on August 20, 2014

Authors

Aedín Cassidy1, Tianyi Huang1, Megan S Rice1, Eric B Rimm1, Shelley S Tworoger1

Author Affiliations

1: From the Department of Nutrition, Norwich Medical School, University of East Anglia, Norwich, United Kingdom (AC); the Department of Epidemiology, Harvard School of Public Health, Boston, MA (TH, MSR, EBR, and SST); and the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (TH, MSR, EBR, and SST).

Articles citing this

A New Database Facilitates Characterization of Flavonoid Intake, Sources, and Positive Associations with Diet Quality among US Adults. J Nutr (2015) 0.95

Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am J Clin Nutr (2015) 0.88

Higher dietary anthocyanin and flavonol intakes are associated with anti-inflammatory effects in a population of US adults. Am J Clin Nutr (2015) 0.81

Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics (2015) 0.78

Ovarian cancer risk and nonisoflavone flavonoids intake: A systematic review of epidemiological studies. J Res Med Sci (2016) 0.78

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health (2016) 0.76

Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis. PLoS One (2016) 0.76

Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity. Adv Nutr (2017) 0.75

Flavonoids and the risk of ovarian cancer. Am J Clin Nutr (2014) 0.75

Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells. Int J Oncol (2016) 0.75

Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest. Int J Oncol (2017) 0.75

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Test of the National Death Index. Am J Epidemiol (1984) 8.46

The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20

Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med (2008) 5.19

Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr (2010) 3.19

Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol (2012) 2.33

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med (2012) 2.22

Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr (2012) 1.78

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76

Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer (2011) 1.69

Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol (2005) 1.69

International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer (1986) 1.51

Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr (2003) 1.34

Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol (1996) 1.33

Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer (2011) 1.30

Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol (2010) 1.29

Vegetable and fruit consumption and cancer risk. Int J Cancer (1991) 1.26

Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr (2009) 1.24

Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology (2009) 1.21

Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer (2008) 1.20

An ecological study on diet/nutrition and cancer in Japan. Int J Cancer (1997) 1.16

Diet and ovarian cancer risk: a case-control study in China. Br J Cancer (2002) 1.12

Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev (2013) 1.12

Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer (2009) 1.11

Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res (2012) 1.10

Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev (2012) 1.09

Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer (2001) 1.06

Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer (2001) 1.05

Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer (2008) 1.03

Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2005) 0.98

Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer (2007) 0.97

Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med (2005) 0.96

Green tea and green tea catechin extracts: an overview of the clinical evidence. Maturitas (2012) 0.94

Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer (2010) 0.92

Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer (2007) 0.91

Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. Br J Nutr (2012) 0.88

Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale (2012) 0.88

Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation. Carcinogenesis (2010) 0.86

Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors. PLoS One (2013) 0.84

Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast Cancer Res Treat (2013) 0.82

Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol (2012) 0.80

Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res (2011) 0.79